Zobrazeno 1 - 10
of 137
pro vyhledávání: '"LMWH, low molecular weight heparin"'
Autor:
Ke-Xin Sun, Bin Cui, Shan-Shan Cao, Qi-Xiang Huang, Ru-Yi Xia, Wen-Jun Wang, Jing-Wen Wang, Feng Yu, Yi Ding
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: The drug therapy of venous thromboembolism (VTE) presents a significant economic burden to the health-care system in low- and middle-income countries. To understand which anticoagulation therapy is most cost-effective for clinical decisio
Externí odkaz:
https://doaj.org/article/828aa36d8b8d4c309ff7c2121a05501c
Autor:
Baranca Buijsers, Cansu Yanginlar, Aline de Nooijer, Inge Grondman, Marissa L. Maciej-Hulme, Inge Jonkman, Nico A. F. Janssen, Nils Rother, Mark de Graaf, Peter Pickkers, Matthijs Kox, Leo A. B. Joosten, Tom Nijenhuis, Mihai G. Netea, Luuk Hilbrands, Frank L. van de Veerdonk, Raphaël Duivenvoorden, Quirijn de Mast, Johan van der Vlag
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Reports suggest a role of endothelial dysfunction and loss of endothelial barrier function in COVID-19. It is well established that the endothelial glycocalyx-degrading enzyme heparanase contributes to vascular leakage and inflammation. Low molecular
Externí odkaz:
https://doaj.org/article/7124b36948634bfb91760aab37446ec7
Autor:
Pasquale Paolisso, Luca Bergamaschi, Emanuela Concetta D’Angelo, Francesco Donati, Maddalena Giannella, Sara Tedeschi, Renato Pascale, Michele Bartoletti, Giulia Tesini, Mauro Biffi, Benilde Cosmi, Carmine Pizzi, Pierluigi Viale, Nazzareno Galié
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
BackgroundHeparin administration in COVID-19 patients is recommended by expert consensus, although evidence about dosage, duration and efficacy are limited. We aim to investigate the association between different dosages of low molecular weight hepar
Externí odkaz:
https://doaj.org/article/8d2bfae2d642419ab402fba43d84de05
Autor:
Neb, Holger, Talbot, Steven Roger, Ruskowski, Katharina, Brkic, Djurdjina, Sonntagbauer, Michael, Adam, Elisabeth Hannah, Knethen, Andreas von, Zacharowski, Kai D., Heinicke, Ulrike
Publikováno v:
Shock. 58:514-523
Background: Severe progression of coronavirus disease 2019 (COVID-19) causes respiratory failure and critical illness. Recently, COVID-19 has been associated with heparanase (HPSE)-induced endothelial barrier dysfunction and inflammation, so called e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fc65037b160ea7d241797a02b9eb3a7
https://doi.org/10.1097/shk.0000000000002021
https://doi.org/10.1097/shk.0000000000002021
Publikováno v:
Bioactive Materials
Bioactive Materials, Vol 6, Iss 7, Pp 1973-1987 (2021)
Bioactive Materials, Vol 6, Iss 7, Pp 1973-1987 (2021)
The tumor development and metastasis are closely related to the structure and function of the tumor microenvironment (TME). Recently, TME modulation strategies have attracted much attention in cancer immunotherapy. Despite the preliminary success of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d9e3a12774af1e45fb188f205ad9bdc
https://doi.org/10.1016/j.bioactmat.2020.12.010
https://doi.org/10.1016/j.bioactmat.2020.12.010
Autor:
Michèle Lehn-Hogg, Pierre Michel, Jonathan Tousch, Lucas Jambert, Naouel Bensalah, Marjolaine Talbot, Amer Hamadé, Laurent Jacquemin, Benjamin Dervieux, Golnaz Obringer, Nathalie Buschenrieder, Olivier Hinschberger, Tarek El Nazer, Bastien Woehl, Dominique Stephan
Publikováno v:
Journal of Vascular Surgery. Venous and Lymphatic Disorders
Journal of Vascular Surgery: Venous and Lymphatic Disorders
Journal of Vascular Surgery: Venous and Lymphatic Disorders
Objective COVID-19 patients may develop coagulopathy which is associated with poor prognosis and high risk of thrombosis. The objective of this work was to evaluate the prevalence of deep venous thrombosis of lower limbs (DVT) through ultrasonography
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f203635d2d0f54c3afecf57b829cea8
https://doi.org/10.1016/j.jvsv.2020.11.019
https://doi.org/10.1016/j.jvsv.2020.11.019
Publikováno v:
The American Journal of Emergency Medicine
Objectives Determine whether D-dimer concentration in the absence of imaging can differentiate patients that require anti-coagulation from patients who do not require anti-coagulation. Methods Data was obtained retrospectively from 366 hemodynamicall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7cbe65577cd00a090d2772e01808c0c
https://doi.org/10.1016/j.ajem.2020.08.086
https://doi.org/10.1016/j.ajem.2020.08.086
Publikováno v:
Journal of Medicine and Life
With the exponential growth of COVID-19 cases, the neurological complications reported during or after the infection became more common. There is limited knowledge regarding the pathophysiological mechanisms that are responsible for these complicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::748f2afbd99e4fd6173f53f6560c4fb8
http://europepmc.org/articles/PMC8169143
http://europepmc.org/articles/PMC8169143
Autor:
Abeer M. Al-Subaie
Publikováno v:
Saudi Journal of Biological Sciences, Vol 28, Iss 1, Pp 956-961 (2021)
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences
The coronavirus disease (COVID-19), which is also known as acute respiratory syndrome coronavirus-2 (SARS-CoV2) is a transmissible disease, has phenotypes varying from asymptomatic to Acute Respiratory Distress Syndrome (ARDS) or multiple organ dysfu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e631f9a498725f1467bb5bfeb73d0842
https://doi.org/10.1016/j.sjbs.2020.11.006
https://doi.org/10.1016/j.sjbs.2020.11.006
Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units
Autor:
Francesco Barsotti, Liliana Villari, Laura Carrozzi, Alessandro Celi, Roberta Pancani, Giulia Parri, Mario Malerba, Rigoletta Vincenti, Valentina Foci, Filippo Patrucco
Publikováno v:
Thrombosis Research
COVID-19 has been associated with an increased risk of thrombotic events; however, the reported incidence of deep vein thrombosis varies depending, at least in part, on the severity of the disease. Aim of this prospective, multicenter, observational
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8f4bd5443c616988c19608476ea7816
https://doi.org/10.1016/j.thromres.2020.10.035
https://doi.org/10.1016/j.thromres.2020.10.035